![]() |
市場調查報告書
商品編碼
1859776
全球寵物生物安全解決方案市場:預測至 2032 年—按產品類型、應用、最終用戶和地區分類的分析Pet Biosecurity Solutions Market Forecasts to 2032 - Global Analysis By Product Type, Application, End User, and By Geography. |
||||||
根據 Stratistics MRC 的數據,全球寵物生物安全解決方案市場預計到 2025 年將達到 93 億美元,到 2032 年將達到 268 億美元,預測期內複合年成長率為 16.3%。
寵物生物安全解決方案是指旨在預防寵物間感染疾病傳播的系統和措施。這些方案包括衛生通訊協定、疫苗接種計劃、隔離程序以及有助於檢測和控制健康風險的監測工具。其目標是保護動物免受病原體侵害,並確保家庭、診所、收容所和公共場所的環境安全。解決方案包括物理屏障、衛生用品以及健康數據的數位追蹤,以維護寵物健康並預防感染疾病爆發。
世界動物衛生組織表示,通用感染疾病的威脅日益加劇,加速了對先進診斷、疫苗和消毒通訊協定的需求,以確保犬舍和獸醫診所等設施的安全。
對通用感染疾病的認知提高
寵物生物安全解決方案市場的發展動力源於人們對通用感染疾病的日益關注,以及保護寵物和人類免受跨物種感染的迫切需求。在全球健康計劃和寵物衛生標準不斷提高的推動下,飼主越來越重視預防保健和衛生用品。狂犬病和鉤端螺旋體病等疾病爆發的報告日益增多,進一步刺激了市場需求。此外,獸醫專業人員對早期發現和控制的重視也加速了相關產品的普及。因此,生物安全解決方案正成為寵物照護中不可或缺的一部分。
消費者意識低下
寵物飼主對生物安全措施的認知不足是限制市場擴張的主要因素。許多消費者除了定期接種疫苗外,對其他感染預防措施知之甚少。這種知識不足阻礙了消毒劑、清潔劑和抗菌寢具等預防性衛生產品的普及。此外,新興地區教育宣傳活動不足和產品供應短缺也加劇了這個問題。為了克服這項限制因素,獸醫組織和生產者需要進行有針對性的宣傳活動,以提高人們對寵物生物安全主動性重要性的認知。
開發創新衛生產品
先進創新衛生解決方案的開發為寵物生物安全解決方案市場帶來了巨大的機會。在生物技術和材料科學進步的推動下,各公司紛紛推出長效消毒劑、病原體特異性噴霧劑和環保消毒劑。這些創新滿足了寵物飼主對無毒和永續產品日益成長的偏好。此外,將智慧包裝和自動化衛生系統整合到獸醫環境中,進一步提升了安全性和便利性。這些技術進步有望重新定義寵物預防性衛生管理。
其他預防措施
疫苗、免疫增強補充劑和天然療法等替代預防措施對市場成長構成顯著威脅。許多寵物飼主更傾向於這些他們認為熟悉且價格低廉的解決方案。此外,頻繁梳理毛髮和使用草藥清洗等傳統消毒方法也減少了對專業生物安全產品的依賴。這種替代效應可能會限制產品滲透率,尤其是在對價格敏感的市場。製造商必須強調其產品已證實的有效性和安全性優勢,以應對其他預防方法的競爭。
新冠疫情顯著提高了寵物飼主對衛生和病原體傳播的認知,加速了生物安全解決方案的普及。初期,供應鏈和獸醫服務的中斷阻礙了產品的供應。然而,人們對寵物相關疾病傳播媒介的日益關注,促使消毒劑、殺菌劑和防護設備的銷售量激增。疫情後的復甦推動了動物收容所和診所衛生通訊協定的製度化。因此,新冠疫情加速了全球寵物生物安全措施的長期制度化。
預計在預測期內,消毒劑和清潔劑細分市場將成為最大的細分市場。
由於消毒劑和清潔劑在消除寵物環境中的有害病原體方面發揮著至關重要的作用,預計在預測期內,該細分市場將佔據最大的市場佔有率。這些產品廣泛應用於診所、收容所和家庭,以降低疾病傳播的風險。人們對寵物衛生和安全飼養意識的提高進一步推動了市場需求。此外,無酒精和寵物安全配方的創新也鞏固了其持續的受歡迎程度。憑藉其可靠性和廣泛的應用範圍,該細分市場正在鞏固其市場主導地位。
預計在預測期內,獸醫院細分市場將以最高的複合年成長率成長。
預計在預測期內,獸醫院領域將實現最高成長率。獸醫專業人員越來越依賴生物安全解決方案來保護動物和工作人員免受交叉感染。診所正在採用先進的消毒劑、滅菌工具和隔離通訊協定,以符合監管指南。此外,寵物治療量的增加以及人們對醫院感染的認知不斷提高,正在加速這些解決方案的採用,使獸醫院成為一個高成長的終端用戶領域。
由於寵物飼養量的增加、可支配收入的成長以及中國、日本和印度等國家獸醫基礎設施的不斷完善,預計亞太地區將在預測期內佔據最大的市場佔有率。人們對通用感染疾病的認知不斷提高以及政府主導的動物健康計劃也進一步推動了市場擴張。此外,全球生物安全公司不斷增加的投資也增強了該地區的產品供應。這些因素共同促成了亞太地區成為寵物生物安全解決方案應用的重要中心。
在預測期內,北美預計將實現最高的複合年成長率,這主要得益於其先進的動物保健體系、較高的寵物消費支出以及對衛生創新技術的早期應用。美國和加拿大對高階生物安全產品的需求激增,這主要受嚴格的動物健康法規的推動。此外,主要市場參與者的強大實力和完善的分銷網路也提高了產品的供應量。持續的產品創新和宣傳宣傳活動預計將繼續推動該地區市場的快速成長。
According to Stratistics MRC, the Global Pet Biosecurity Solutions Market is accounted for $9.3 billion in 2025 and is expected to reach $26.8 billion by 2032 growing at a CAGR of 16.3% during the forecast period. Pet Biosecurity Solutions are systems and practices aimed at preventing the spread of infectious diseases among pets. These include hygiene protocols, vaccination programs, quarantine procedures, and monitoring tools that help detect and control health risks. The goal is to protect animals from pathogens and ensure safe environments in homes, clinics, shelters, and public spaces. Solutions may involve physical barriers, sanitation products, and digital tracking of health data to maintain wellness and prevent outbreaks.
According to the World Organisation for Animal Health, rising zoonotic disease threats are accelerating demand for advanced diagnostics, vaccines, and disinfection protocols to secure facilities like kennels and veterinary hospitals.
Rising zoonotic disease awareness
The Pet Biosecurity Solutions Market is being driven by increasing awareness of zoonotic diseases and the critical need to protect both pets and humans from cross-species infections. Fueled by global health initiatives and heightened pet hygiene standards, owners are prioritizing preventive care and sanitation products. Rising media coverage of outbreaks such as rabies and leptospirosis further reinforces demand. Additionally, veterinary professionals emphasize early detection and containment practices, accelerating product adoption. Consequently, biosecurity solutions are becoming indispensable in pet care.
Limited consumer awareness
Limited awareness among pet owners regarding biosecurity measures acts as a key restraint in market expansion. Many consumers remain unaware of infection control practices beyond routine vaccinations. This knowledge gap hinders adoption of preventive hygiene products like disinfectants, sanitizers, and antimicrobial bedding. Furthermore, insufficient education campaigns and product accessibility in emerging regions exacerbate the issue. Overcoming this restraint requires targeted outreach by veterinary organizations and manufacturers to promote the importance of proactive pet biosecurity.
Development of innovative hygiene products
The development of advanced and innovative hygiene solutions presents significant opportunities in the Pet Biosecurity Solutions Market. Spurred by advancements in biotechnology and materials science, companies are introducing long-lasting disinfectants, pathogen-specific sprays, and eco-friendly sanitizers. These innovations cater to the growing preference for non-toxic and sustainable products among pet owners. Additionally, integration of smart packaging and automated hygiene systems in veterinary settings enhances safety and convenience. This technological evolution is expected to redefine preventive pet health management.
Alternative preventive measures
Alternative preventive measures such as vaccines, immune-boosting supplements, and natural remedies pose a notable threat to market growth. Many pet owners prefer these solutions due to their familiarity and perceived lower cost. Moreover, traditional disinfection practices like frequent grooming or herbal cleaning reduce dependence on specialized biosecurity products. This substitution effect may limit product penetration, particularly in cost-sensitive markets. Manufacturers must emphasize proven efficacy and safety advantages to counter competition from alternative preventive approaches.
The COVID-19 pandemic significantly heightened awareness of hygiene and pathogen transmission among pet owners, accelerating adoption of biosecurity solutions. Initially, disruptions in supply chains and veterinary services hampered product availability. However, rising concerns over pet-related disease vectors boosted sales of sanitizers, disinfectants, and protective equipment. Post-pandemic recovery saw increased institutional adoption of hygiene protocols in shelters and clinics. Consequently, COVID-19 served as a catalyst for the long-term institutionalization of pet biosecurity practices worldwide.
The disinfectants & sanitizers segment is expected to be the largest during the forecast period
The disinfectants & sanitizers segment is expected to account for the largest market share during the forecast period, resulting from their critical role in eliminating harmful pathogens from pet environments. These products are extensively used in clinics, shelters, and households to reduce disease transmission risk. Growing awareness of pet hygiene and safe handling practices further enhances demand. Additionally, innovations in alcohol-free, pet-safe formulations support sustained adoption. This segment's reliability and broad applicability solidify its dominant market position.
The veterinary clinics segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the veterinary clinics segment is predicted to witness the highest growth rate, propelled by rising implementation of strict sanitation standards and infection control measures. Veterinary professionals increasingly rely on biosecurity solutions to safeguard animals and staff from cross-contamination. Clinics are adopting advanced disinfectants, sterilization tools, and isolation protocols to comply with regulatory guidelines. Moreover, growing pet treatment volumes and awareness of hospital-acquired infections are accelerating adoption, making veterinary clinics a high-growth end-use segment.
During the forecast period, the Asia Pacific region is expected to hold the largest market share, attributed to expanding pet ownership, rising disposable incomes, and growing veterinary infrastructure in countries like China, Japan, and India. Heightened awareness of zoonotic diseases and government-driven animal health programs further stimulate market expansion. Additionally, increasing investments by global biosecurity companies strengthen regional product availability. These factors collectively position Asia Pacific as a major hub for pet biosecurity solution adoption.
Over the forecast period, the North America region is anticipated to exhibit the highest CAGR associated with advanced veterinary healthcare systems, high pet expenditure, and early adoption of hygiene innovations. The U.S. and Canada are witnessing surging demand for premium biosecurity products supported by stringent animal health regulations. Furthermore, the strong presence of key market players and robust distribution networks enhances accessibility. Continuous product innovation and awareness campaigns are expected to sustain rapid market growth in the region.
Key players in the market
Some of the key players in Pet Biosecurity Solutions Market include 3M Company, Elanco Animal Health, BASF SE, Stockmeier Group, DuPont de Nemours, Inc., Kersia Group, Thermo Fisher Scientific Inc., Kemin Industries Inc., Ecolab Inc., Evonik Industries AG, Zoetis Inc., Solvay S.A., Neogen Corporation, BASF Animal Nutrition, Lanxess AG, Bayer Animal Health, GEA Group Aktiengesellschaft, and Merck Animal Health.
In September 2025, Zoetis presented new data on BRAVECTO(R) injectable at WSAVA Congress, highlighting rapid onset and safety. The company also donated its 7 millionth rabies vaccine through the Afya Program
In August 2025, Lanxess AG showcased Virkon(R), TH4+(R), and Hyperox(R) at IPPE 2025, reinforcing its leadership in animal biosecurity. The company emphasized sustainability and compliance in poultry and livestock hygiene
In April 2025, Stockmeier Group expanded its disinfectant portfolio in India via Saife Vetmed, launching enzymatic cleaners for livestock and companion animals. The collaboration targets Southeast Asia, Middle East, and Africa